Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
88%
Chemoradiotherapy
24%
Prostate Cancer
20%
Squamous Cell Carcinoma
18%
Diseases
16%
Magnetic Resonance Imaging
16%
Recurrent Disease
15%
Brain Metastasis
15%
Neck
15%
Head and Neck Cancer
14%
Hypoxia
13%
Breast Cancer
13%
Positron Emission Tomography
13%
Ganglioglioma
13%
Stereotactic Radiotherapy
13%
Non Small Cell Lung Cancer
13%
Overall Survival
12%
Surgery
12%
Conformal Radiotherapy
11%
Radiation Oncology
11%
Hyperthermia
11%
Tumor Cell
11%
In Vitro
11%
Side Effect
10%
Intensity Modulated Radiation Therapy
9%
Prognostic Factor
9%
Treatment Planning
8%
Malignant Neoplasm
8%
Metastatic Carcinoma
8%
Glioblastoma
8%
Survival Rate
8%
Relative Biologic Effectiveness
8%
Soft Tissue Sarcoma
7%
Tomotherapy
7%
Carbon 11
7%
Mouse Embryo
7%
Plasminogen Activator Inhibitor-1
7%
External Beam Radiotherapy
7%
Head and Neck Tumor
7%
Methionine
6%
Vasculotropin
6%
Quality of Life
6%
Tumor Hypoxia
6%
Meningioma
6%
Phase II Trials
6%
Drug Megadose
6%
Rectum Cancer
6%
Lymph Node
6%
Radiation Treatment Planning
6%
Keyphrases
Radiotherapy
65%
Tumor
53%
Irradiation
36%
Radiation Therapy
29%
Chemotherapy
22%
Radiochemotherapy
19%
Brain Metastases
17%
Head-and-neck Cancer
15%
Hypoxia
15%
Head-and-neck
14%
Hyperthermia
13%
Radiation Oncology
12%
Postoperative Radiotherapy
11%
Tumor Cells
10%
Overall Survival
10%
Tumor Oxygenation
10%
Total Dose
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Gross Tumor Volume
9%
Heat Shock Protein 70 (HSP70)
9%
Radiation Dose
9%
Esophageal Squamous Cell Carcinoma
9%
Prostate Cancer
9%
Locally Advanced
9%
Local Control
8%
Tumor Volume
8%
Prognostic Factors
8%
Breast Cancer
8%
Squamous Cell Carcinoma of Head
8%
Positron Emission Tomography
8%
Fractionated Stereotactic Radiotherapy
8%
Combined Modality Therapy
8%
Localized Prostate Cancer
8%
Cisplatin
8%
Radiation Effects
7%
Quality of Life
7%
Local Recurrence
7%
Survival Rate
7%
Stereotactic Radiotherapy
7%
Plasminogen Activator inhibitor-1 (PAI-1)
7%
Mouse Embryo
7%
Radiation Treatment Planning
7%
Neck Tumor
7%
Tumor Hypoxia
7%
Dose Escalation
7%
Thermoradiotherapy
7%
Neoadjuvant Radiotherapy
7%
MeV Protons
7%
11C-methionine Positron Emission Tomography
6%
Oxygenation Status
6%